United States Healthcare Equipment & Supplies

Clover Health Investments Corp (CLOV)

Track

Track

Clover Health Investments Corp experienced significant insider selling over the past ninety days, totaling approximately 2.8 million dollars in net value. Executives, including the CEO and CFO, executed multiple divestments following a positive earnings report. These transactions reflect a consistent pattern of planned sales by leadership amidst an eighteen percent rise in stock price.
Ticker: CLOV Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Clover Health Investments Corp. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
THORNTON JOSEPH CLAY Interim CFO Officer
Transaction date
Sale
Price
97.34
Quantity 42,500 -28.9%
Value US$677,799
Joseph Clay Thornton Officer Officer
Transaction date
Proposed sale
Price
389.05
Quantity 1,201
Value US$244,447
1.9
BRADY PRIEST Officer Officer
Transaction date
Proposed sale
Price
399.73
Quantity 80,465
Value US$1,429,802
Toy Andrew Chief Executive Officer Executive Director
Transaction date
Sale
Price
4.65
Quantity 1,000 -0.9%
Value US$100,000
Andrew Toy Officer Officer
Transaction date
Proposed sale
Price
4.57
Quantity 1,000
Value US$100,000
1.9
BRADY PRIEST Officer Officer
Transaction date
Proposed sale
Price
4.85
Quantity 1,000
Value US$100,000
3.3
Soares Karen Chief Legal Officer Officer
Transaction date
Planned sale
Price
4.51
Quantity 51,700 -3.3%
Value US$233,167
3.3
KAREN SOARES Officer Officer
Transaction date
Proposed sale
Price
4.62
Quantity 51,700
Value US$238,854
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Planned sale
Price
4.53
Quantity 4,839 -0.2%
Value US$21,921
JAMIE REYNOSO Officer Officer
Transaction date
Proposed sale
Price
4.40
Quantity 4,839
Value US$21,292
Toy Andrew Chief Executive Officer Executive Director
Transaction date
Sale
Price
4.67
Quantity 62,711 -0.7%
Value US$292,860
Wai Conrad CEO, Counterpart Health Officer
Transaction date
Sale
Price
4.67
Quantity 24,215 -2.1%
Value US$113,084
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Sale
Price
4.67
Quantity 13,119 -0.5%
Value US$61,266
3.3
Soares Karen Chief Legal Officer Officer
Transaction date
Sale
Price
4.67
Quantity 10,519 -0.7%
Value US$49,124
THORNTON JOSEPH CLAY Interim CFO Officer
Transaction date
Sale
Price
4.67
Quantity 4,630 -0.4%
Value US$21,622
Joseph Clay Thornton Officer Officer
Transaction date
Proposed sale
Price
4.68
Quantity 4,486
Value US$20,994
3.3
Karen Soares Officer Officer
Transaction date
Proposed sale
Price
4.68
Quantity 10,192
Value US$47,699
Jamie Reynoso Officer Officer
Transaction date
Proposed sale
Price
4.68
Quantity 12,712
Value US$59,492
Andrew Toy Officer Officer
Transaction date
Proposed sale
Price
4.68
Quantity 60,765
Value US$284,380
Conrad Wai Officer Officer
Transaction date
Proposed sale
Price
4.68
Quantity 23,463
Value US$109,807
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Planned sale
Price
4.68
Quantity 2,384 -0.1%
Value US$11,157
JAMIE REYNOSO Officer Officer
Transaction date
Proposed sale
Price
5.00
Quantity 2,384
Value US$11,920
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Sale
Price
5.26
Quantity 6,229 -0.2%
Value US$32,765
Jamie Reynoso Officer Officer
Transaction date
Proposed sale
Price
5.26
Quantity 6,229
Value US$32,765
Toy Andrew Chief Executive Officer Executive Director
Transaction date
Sale
Price
5.32
Quantity 313,476 -3.2%
Value US$1,667,692
Andrew Toy Officer Officer
Transaction date
Proposed sale
Price
5.39
Quantity 309,558
Value US$1,668,518
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Planned sale
Price
4.78
Quantity 2,360 -0.1%
Value US$11,281
JAMIE REYNOSO Officer Officer
Transaction date
Proposed sale
Price
4.94
Quantity 2,360
Value US$11,658
OLDAKOWSKI JOSEPH FRANK VP OF FINANCE AND CONTROLLER Officer
Transaction date
Sale
Price
4.86
Quantity 12,102 -3.9%
Value US$58,816
3.3
Soares Karen Chief Legal Officer Officer
Transaction date
Sale
Price
4.61
Quantity 4,681 -0.3%
Value US$21,579
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Sale
Price
4.61
Quantity 6,350 -0.2%
Value US$29,274
3.3
Karen Soares Officer Officer
Transaction date
Proposed sale
Price
4.81
Quantity 5,342
Value US$25,695
Jamie Reynoso Officer Officer
Transaction date
Proposed sale
Price
4.81
Quantity 7,556
Value US$36,344
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Planned sale
Price
4.91
Quantity 7,289 -0.3%
Value US$35,789
JAMIE REYNOSO Officer Officer
Transaction date
Proposed sale
Price
4.89
Quantity 7,289
Value US$35,643
JAMIE REYNOSO Officer Officer
Transaction date
Proposed sale
Price
4.89
Quantity 7,289
Value US$35,643
Wai Conrad CEO, Counterpart Health Officer
Transaction date
Planned sale
Price
3.99
Quantity 220,426 -13.7%
Value US$879,500
Wai Conrad Officer Officer
Transaction date
Proposed sale
Price
3.99
Quantity 220,426
Value US$880,577
2.9
CARLADENISE A EDWARDS Director Non-Executive Director
Transaction date
Proposed sale
Price
3.41
Quantity 67,160
Value US$229,130
2.9
CARLADENISE A EDWARDS Director Non-Executive Director
Transaction date
Proposed sale
Price
3.41
Quantity 67,160
Value US$229,130
4.0
Kuipers Peter J. former CFO
Transaction date
Proposed sale
Price
3.45
Quantity 886,341
Value US$3,057,876
1.9
Priest Brady Patrick CEO of Clover Care Services Officer
Transaction date
Sale
Price
3.52
Quantity 98,039 -4.6%
Value US$345,097
1.9
BRADY PRIEST Officer Officer
Transaction date
Proposed sale
Price
3.52
Quantity 98,039
Value US$345,107
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Planned sale
Price
1.91
Quantity 5,833 -0.2%
Value US$11,141
JAMIE REYNOSO Officer Officer
Transaction date
Proposed sale
Price
1.93
Quantity 5,833
Value US$11,258
1.9
Priest Brady Patrick CEO of Home Care Officer
Transaction date
Sale
Price
2.17
Quantity 175,000 -8.1%
Value US$379,750
1.9
BRADY PRIEST Officer Officer
Transaction date
Proposed sale
Price
2.17
Quantity 175,000
Value US$378,945
JAMIE REYNOSO Officer Officer
Transaction date
Proposed sale
Price
2.54
Quantity 4,597
Value US$11,676
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Planned sale
Price
2.58
Quantity 4,597 -0.2%
Value US$11,860
JAMIE REYNOSO Officer Officer
Transaction date
Proposed sale
Price
2.59
Quantity 2,102
Value US$5,444
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Planned sale
Price
2.53
Quantity 2,102 -0.1%
Value US$5,318
JAMIE REYNOSO Officer Officer
Transaction date
Proposed sale
Price
2.60
Quantity 4,913
Value US$12,774
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Planned sale
Price
2.61
Quantity 4,913 -0.2%
Value US$12,823
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Planned sale
Price
3.58
Quantity 30,385 -1.1%
Value US$108,778
JAMIE REYNOSO Officer Officer
Transaction date
Proposed sale
Price
3.68
Quantity 30,385
Value US$111,817
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Planned sale
Price
2.69
Quantity 16,514 -0.6%
Value US$44,423
JAMIE REYNOSO Officer Officer
Transaction date
Proposed sale
Price
2.70
Quantity 16,514
Value US$44,588
JAMIE REYNOSO Officer Officer
Transaction date
Proposed sale
Price
2.62
Quantity 2,012
Value US$5,271
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Planned sale
Price
2.65
Quantity 2,012 -0.1%
Value US$5,332
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Planned sale
Price
3.09
Quantity 4,914 -0.2%
Value US$15,184
JAMIE REYNOSO Officer Officer
Transaction date
Proposed sale
Price
3.12
Quantity 4,914
Value US$15,332
3.5
Loengard Anna U Non-Executive Director
Transaction date
Purchase
Price
2.59
Quantity 14,500 +96.0%
Value US$37,555
3.5
Loengard Anna U Non-Executive Director
Transaction date
Purchase
Price
2.60
Quantity 12,000 +76.9%
Value US$31,200
4.1
Garipalli Vivek Non-Executive Director Large shareholder
Transaction date
Purchase
Price
2.17
Quantity 31,980 +1.8%
Value US$69,397
4.1
Garipalli Vivek Non-Executive Director Large shareholder
Transaction date
Purchase
Price
2.24
Quantity 415,000 +29.4%
Value US$929,600
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Planned sale
Price
2.89
Quantity 6,823 -0.2%
Value US$19,718
JAMIE REYNOSO Officer Officer
Transaction date
Proposed sale
Price
2.78
Quantity 6,823
Value US$18,968
Wai Conrad CEO, Counterpart Health Officer
Transaction date
Planned sale
Price
3.32
Quantity 91,197 -6.1%
Value US$302,774
Wai Conrad CEO, Counterpart Health Officer
Transaction date
Planned sale
Price
3.29
Quantity 118,600 -7.4%
Value US$390,194
Wai Conrad Officer Officer
Transaction date
Proposed sale
Price
3.25
Quantity 225,000
Value US$731,250
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Planned sale
Price
2.85
Quantity 2,012 -0.1%
Value US$5,734
JAMIE REYNOSO Officer Officer
Transaction date
Proposed sale
Price
2.56
Quantity 2,012
Value US$5,151
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Planned sale
Price
2.58
Quantity 19,789 -0.6%
Value US$51,056
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-17 2026-08-17 S Sale
THORNTON JOSEPH CLAY

Interim CFO

Officer
42,500 -28.9%
97.34
US$677,799 		42,500 -28.9% 97.34 US$677,799
2026-08-17 2026-08-17 PrS Proposed sale
Joseph Clay Thornton

Officer

Officer
1,201
389.05
US$244,447 		1,201 389.05 US$244,447
2026-08-14 2026-08-14 PrS Proposed sale
1.9
BRADY PRIEST

Officer

Officer
80,465
399.73
US$1,429,802 		80,465 399.73 US$1,429,802
2026-08-10 2026-08-10 S Sale
Toy Andrew

Chief Executive Officer

Executive Director
1,000 -0.9%
4.65
US$100,000 		1,000 -0.9% 4.65 US$100,000
2026-08-10 2026-08-10 PrS Proposed sale
Andrew Toy

Officer

Officer
1,000
4.57
US$100,000 		1,000 4.57 US$100,000
2026-08-07 2026-08-07 PrS Proposed sale
1.9
BRADY PRIEST

Officer

Officer
1,000
4.85
US$100,000 		1,000 4.85 US$100,000
2026-07-20 2026-07-20 PlS Planned sale
3.3
Soares Karen

Chief Legal Officer

Officer
51,700 -3.3%
4.51
US$233,167 		51,700 -3.3% 4.51 US$233,167
2026-07-20 2026-07-20 PrS Proposed sale
3.3
KAREN SOARES

Officer

Officer
51,700
4.62
US$238,854 		51,700 4.62 US$238,854
2026-07-17 2026-07-17 PlS Planned sale
Reynoso Jamie L.

CEO, Medicare Advantage

Officer
4,839 -0.2%
4.53
US$21,921 		4,839 -0.2% 4.53 US$21,921
2026-07-17 2026-07-17 PrS Proposed sale
JAMIE REYNOSO

Officer

Officer
4,839
4.40
US$21,292 		4,839 4.40 US$21,292
2026-07-16 2026-07-15 S Sale
Toy Andrew

Chief Executive Officer

Executive Director
62,711 -0.7%
4.67
US$292,860 		62,711 -0.7% 4.67 US$292,860
2026-07-16 2026-07-15 S Sale
Wai Conrad

CEO, Counterpart Health

Officer
24,215 -2.1%
4.67
US$113,084 		24,215 -2.1% 4.67 US$113,084
2026-07-16 2026-07-15 S Sale
Reynoso Jamie L.

CEO, Medicare Advantage

Officer
13,119 -0.5%
4.67
US$61,266 		13,119 -0.5% 4.67 US$61,266
2026-07-16 2026-07-15 S Sale
3.3
Soares Karen

Chief Legal Officer

Officer
10,519 -0.7%
4.67
US$49,124 		10,519 -0.7% 4.67 US$49,124
2026-07-16 2026-07-15 S Sale
THORNTON JOSEPH CLAY

Interim CFO

Officer
4,630 -0.4%
4.67
US$21,622 		4,630 -0.4% 4.67 US$21,622
2026-07-15 2026-07-15 PrS Proposed sale
Joseph Clay Thornton

Officer

Officer
4,486
4.68
US$20,994 		4,486 4.68 US$20,994
2026-07-15 2026-07-15 PrS Proposed sale
3.3
Karen Soares

Officer

Officer
10,192
4.68
US$47,699 		10,192 4.68 US$47,699
2026-07-15 2026-07-15 PrS Proposed sale
Jamie Reynoso

Officer

Officer
12,712
4.68
US$59,492 		12,712 4.68 US$59,492
2026-07-15 2026-07-15 PrS Proposed sale
Andrew Toy

Officer

Officer
60,765
4.68
US$284,380 		60,765 4.68 US$284,380
2026-07-15 2026-07-15 PrS Proposed sale
Conrad Wai

Officer

Officer
23,463
4.68
US$109,807 		23,463 4.68 US$109,807
2026-07-09 2026-07-08 PlS Planned sale
Reynoso Jamie L.

CEO, Medicare Advantage

Officer
2,384 -0.1%
4.68
US$11,157 		2,384 -0.1% 4.68 US$11,157
2026-07-08 2026-07-08 PrS Proposed sale
JAMIE REYNOSO

Officer

Officer
2,384
5.00
US$11,920 		2,384 5.00 US$11,920
2026-07-06 2026-07-06 S Sale
Reynoso Jamie L.

CEO, Medicare Advantage

Officer
6,229 -0.2%
5.26
US$32,765 		6,229 -0.2% 5.26 US$32,765
2026-07-06 2026-07-06 PrS Proposed sale
Jamie Reynoso

Officer

Officer
6,229
5.26
US$32,765 		6,229 5.26 US$32,765
2026-07-01 2026-07-01 S Sale
Toy Andrew

Chief Executive Officer

Executive Director
313,476 -3.2%
5.32
US$1,667,692 		313,476 -3.2% 5.32 US$1,667,692
2026-07-01 2026-07-01 PrS Proposed sale
Andrew Toy

Officer

Officer
309,558
5.39
US$1,668,518 		309,558 5.39 US$1,668,518
2026-06-18 2026-06-17 PlS Planned sale
Reynoso Jamie L.

CEO, Medicare Advantage

Officer
2,360 -0.1%
4.78
US$11,281 		2,360 -0.1% 4.78 US$11,281
2026-06-17 2026-06-17 PrS Proposed sale
JAMIE REYNOSO

Officer

Officer
2,360
4.94
US$11,658 		2,360 4.94 US$11,658
2026-06-17 2026-06-16 S Sale
OLDAKOWSKI JOSEPH FRANK

VP OF FINANCE AND CONTROLLER

Officer
12,102 -3.9%
4.86
US$58,816 		12,102 -3.9% 4.86 US$58,816
2026-06-16 2026-06-16 PrS Proposed sale
Joseph Frank Oldakowski

Officer

Officer
14,155
4.94
US$69,926 		14,155 4.94 US$69,926
2026-06-16 2026-06-15 S Sale
3.3
Soares Karen

Chief Legal Officer

Officer
4,681 -0.3%
4.61
US$21,579 		4,681 -0.3% 4.61 US$21,579
2026-06-16 2026-06-15 S Sale
Reynoso Jamie L.

CEO, Medicare Advantage

Officer
6,350 -0.2%
4.61
US$29,274 		6,350 -0.2% 4.61 US$29,274
2026-06-15 2026-06-15 PrS Proposed sale
3.3
Karen Soares

Officer

Officer
5,342
4.81
US$25,695 		5,342 4.81 US$25,695
2026-06-15 2026-06-15 PrS Proposed sale
Jamie Reynoso

Officer

Officer
7,556
4.81
US$36,344 		7,556 4.81 US$36,344
2026-06-11 2026-06-11 PlS Planned sale
Reynoso Jamie L.

CEO, Medicare Advantage

Officer
7,289 -0.3%
4.91
US$35,789 		7,289 -0.3% 4.91 US$35,789
2026-06-11 2026-06-11 PrS Proposed sale
JAMIE REYNOSO

Officer

Officer
7,289
4.89
US$35,643 		7,289 4.89 US$35,643
2026-06-11 2026-06-11 PrS Proposed sale
JAMIE REYNOSO

Officer

Officer
7,289
4.89
US$35,643 		7,289 4.89 US$35,643
2026-05-28 2026-05-28 PlS Planned sale
Wai Conrad

CEO, Counterpart Health

Officer
220,426 -13.7%
3.99
US$879,500 		220,426 -13.7% 3.99 US$879,500
2026-05-28 2026-05-28 PrS Proposed sale
Wai Conrad

Officer

Officer
220,426
3.99
US$880,577 		220,426 3.99 US$880,577
2026-05-19 2026-05-18 S Sale
2.9
Edwards Carladenise Armbrister
Non-Executive Director
67,160 -19.0%
3.42
US$229,687 		67,160 -19.0% 3.42 US$229,687
2026-05-18 2026-05-18 PrS Proposed sale
2.9
CARLADENISE A EDWARDS

Director

Non-Executive Director
67,160
3.41
US$229,130 		67,160 3.41 US$229,130
2026-05-18 2026-05-18 PrS Proposed sale
2.9
CARLADENISE A EDWARDS

Director

Non-Executive Director
67,160
3.41
US$229,130 		67,160 3.41 US$229,130
2026-05-14 2026-05-14 PrS Proposed sale
4.0
Kuipers Peter J.

former CFO
886,341
3.45
US$3,057,876 		886,341 3.45 US$3,057,876
2026-05-13 2026-05-13 S Sale
1.9
Priest Brady Patrick

CEO of Clover Care Services

Officer
98,039 -4.6%
3.52
US$345,097 		98,039 -4.6% 3.52 US$345,097
2026-05-13 2026-05-13 PrS Proposed sale
1.9
BRADY PRIEST

Officer

Officer
98,039
3.52
US$345,107 		98,039 3.52 US$345,107
2026-03-18 2026-03-18 PlS Planned sale
Reynoso Jamie L.

CEO, Medicare Advantage

Officer
5,833 -0.2%
1.91
US$11,141 		5,833 -0.2% 1.91 US$11,141
2026-03-18 2026-03-18 PrS Proposed sale
JAMIE REYNOSO

Officer

Officer
5,833
1.93
US$11,258 		5,833 1.93 US$11,258
2026-03-05 2026-03-04 S Sale
1.9
Priest Brady Patrick

CEO of Home Care

Officer
175,000 -8.1%
2.17
US$379,750 		175,000 -8.1% 2.17 US$379,750
2026-03-04 2026-03-04 PrS Proposed sale
1.9
BRADY PRIEST

Officer

Officer
175,000
2.17
US$378,945 		175,000 2.17 US$378,945
2026-01-20 2026-01-20 PrS Proposed sale
JAMIE REYNOSO

Officer

Officer
4,597
2.54
US$11,676 		4,597 2.54 US$11,676
2026-01-20 2026-01-20 PlS Planned sale
Reynoso Jamie L.

CEO, Medicare Advantage

Officer
4,597 -0.2%
2.58
US$11,860 		4,597 -0.2% 2.58 US$11,860
2026-01-07 2026-01-07 PrS Proposed sale
JAMIE REYNOSO

Officer

Officer
2,102
2.59
US$5,444 		2,102 2.59 US$5,444
2026-01-07 2026-01-07 PlS Planned sale
Reynoso Jamie L.

CEO, Medicare Advantage

Officer
2,102 -0.1%
2.53
US$5,318 		2,102 -0.1% 2.53 US$5,318
2025-12-18 2025-12-18 PrS Proposed sale
JAMIE REYNOSO

Officer

Officer
4,913
2.60
US$12,774 		4,913 2.60 US$12,774
2025-12-18 2025-12-18 PlS Planned sale
Reynoso Jamie L.

CEO, Medicare Advantage

Officer
4,913 -0.2%
2.61
US$12,823 		4,913 -0.2% 2.61 US$12,823
2025-11-05 2025-11-04 PlS Planned sale
Reynoso Jamie L.

CEO, Medicare Advantage

Officer
30,385 -1.1%
3.58
US$108,778 		30,385 -1.1% 3.58 US$108,778
2025-11-04 2025-11-04 PrS Proposed sale
JAMIE REYNOSO

Officer

Officer
30,385
3.68
US$111,817 		30,385 3.68 US$111,817
2025-10-21 2025-10-17 PlS Planned sale
Reynoso Jamie L.

CEO, Medicare Advantage

Officer
16,514 -0.6%
2.69
US$44,423 		16,514 -0.6% 2.69 US$44,423
2025-10-17 2025-10-17 PrS Proposed sale
JAMIE REYNOSO

Officer

Officer
16,514
2.70
US$44,588 		16,514 2.70 US$44,588
2025-10-07 2025-10-07 PrS Proposed sale
JAMIE REYNOSO

Officer

Officer
2,012
2.62
US$5,271 		2,012 2.62 US$5,271
2025-10-07 2025-10-07 PlS Planned sale
Reynoso Jamie L.

CEO, Medicare Advantage

Officer
2,012 -0.1%
2.65
US$5,332 		2,012 -0.1% 2.65 US$5,332
2025-09-19 2025-09-17 PlS Planned sale
Reynoso Jamie L.

CEO, Medicare Advantage

Officer
4,914 -0.2%
3.09
US$15,184 		4,914 -0.2% 3.09 US$15,184
2025-09-17 2025-09-17 PrS Proposed sale
JAMIE REYNOSO

Officer

Officer
4,914
3.12
US$15,332 		4,914 3.12 US$15,332
2025-08-14 2025-08-13 B Purchase
3.5
Loengard Anna U
Non-Executive Director
14,500 +96.0%
2.59
US$37,555 		14,500 +96.0% 2.59 US$37,555
2025-08-14 2025-08-13 B Purchase
3.5
Loengard Anna U
Non-Executive Director
12,000 +76.9%
2.60
US$31,200 		12,000 +76.9% 2.60 US$31,200
2025-08-08 2025-08-08 B Purchase
4.1
Garipalli Vivek
Non-Executive Director Large shareholder
31,980 +1.8%
2.17
US$69,397 		31,980 +1.8% 2.17 US$69,397
2025-08-08 2025-08-07 B Purchase
4.1
Garipalli Vivek
Non-Executive Director Large shareholder
415,000 +29.4%
2.24
US$929,600 		415,000 +29.4% 2.24 US$929,600
2025-08-06 2025-08-04 PlS Planned sale
Reynoso Jamie L.

CEO, Medicare Advantage

Officer
6,823 -0.2%
2.89
US$19,718 		6,823 -0.2% 2.89 US$19,718
2025-08-04 2025-08-04 PrS Proposed sale
JAMIE REYNOSO

Officer

Officer
6,823
2.78
US$18,968 		6,823 2.78 US$18,968
2025-07-24 2025-07-23 PlS Planned sale
Wai Conrad

CEO, Counterpart Health

Officer
91,197 -6.1%
3.32
US$302,774 		91,197 -6.1% 3.32 US$302,774
2025-07-24 2025-07-22 PlS Planned sale
Wai Conrad

CEO, Counterpart Health

Officer
118,600 -7.4%
3.29
US$390,194 		118,600 -7.4% 3.29 US$390,194
2025-07-08 2025-07-08 PrS Proposed sale
Wai Conrad

Officer

Officer
225,000
3.25
US$731,250 		225,000 3.25 US$731,250
2025-07-08 2025-07-07 PlS Planned sale
Reynoso Jamie L.

CEO, Medicare Advantage

Officer
2,012 -0.1%
2.85
US$5,734 		2,012 -0.1% 2.85 US$5,734
2025-07-07 2025-07-07 PrS Proposed sale
JAMIE REYNOSO

Officer

Officer
2,012
2.56
US$5,151 		2,012 2.56 US$5,151
2025-07-08 2025-07-03 PlS Planned sale
Reynoso Jamie L.

CEO, Medicare Advantage

Officer
19,789 -0.6%
2.58
US$51,056 		19,789 -0.6% 2.58 US$51,056
Explore more

More insider trading research around Clover Health Investments Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America